Transamerica Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4M | Sell |
7,631
-220
| -3% | -$97.9K | 0.32% | 78 |
|
|
2025
Q1 | $3.81M | Sell |
7,851
-101
| -1% | -$49K | 0.39% | 66 |
|
|
2024
Q4 | $3.2M | Sell |
7,952
-222
| -3% | -$89.4K | 0.32% | 82 |
|
|
2024
Q3 | $3.8M | Buy |
8,174
+7,713
| +1,673% | +$3.59M | 0.37% | 76 |
|
|
2024
Q2 | $216K | Hold |
461
| – | – | 0.02% | 195 |
|
|
2024
Q1 | $193K | Sell |
461
-3,004
| -87% | -$1.26M | 0.02% | 218 |
|
|
2023
Q4 | $1.41M | Sell |
3,465
-1,120
| -24% | -$456K | 0.19% | 86 |
|
|
2023
Q3 | $1.6M | Sell |
4,585
-1,065
| -19% | -$370K | 0.22% | 82 |
|
|
2023
Q2 | $1.99M | Buy |
5,650
+167
| +3% | +$58.8K | 0.26% | 66 |
|
|
2023
Q1 | $1.73M | Sell |
5,483
-156
| -3% | -$49.2K | 0.23% | 76 |
|
|
2022
Q4 | $1.63M | Hold |
5,639
| – | – | 0.23% | 83 |
|
|
2022
Q3 | $1.63M | Buy |
5,639
+253
| +5% | +$73.3K | 0.24% | 70 |
|
|
2022
Q2 | $1.52M | Buy |
+5,386
| New | +$1.52M | 0.21% | 67 |
|
|
2021
Q3 | – | Sell |
-5
| Closed | -$1K | – | 200 |
|
|
2021
Q2 | $1K | Buy |
+5
| New | +$1K | 0.02% | 194 |
|
|
2016
Q2 | – | Sell |
-259
| Closed | -$21K | – | 702 |
|
|
2016
Q1 | $21K | Sell |
259
-191
| -42% | -$15.5K | ﹤0.01% | 480 |
|
|
2015
Q4 | $57K | Hold |
450
| – | – | ﹤0.01% | 393 |
|
|
2015
Q3 | $47K | Sell |
450
-410
| -48% | -$42.8K | ﹤0.01% | 395 |
|
|
2015
Q2 | $107K | Buy |
860
+425
| +98% | +$52.9K | 0.01% | 378 |
|
|
2015
Q1 | $52K | Buy |
+435
| New | +$52K | ﹤0.01% | 434 |
|